Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.32 USD | -3.75% | -6.22% | +0.29% |
May. 15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
May. 14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.29% | 465M | |
+63.65% | 62.59B | |
-1.89% | 41.18B | |
+44.59% | 40.29B | |
-8.29% | 27.9B | |
+12.29% | 26.21B | |
-21.66% | 19.09B | |
+5.35% | 13.08B | |
+25.37% | 12.26B | |
+28.33% | 12.05B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- B. Riley Lowers Frequency Therapeutics' Price Target to $17 from $21 After Revising Cost Capital Assumptions, Keeps Buy Rating